West Pharmaceutical Services | WST - Operating Profit



West Pharmaceutical Services reported $153.7M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Align Technology USD 163.03M 31.93M Jun/2025
Avanos Medical USD -53660000 63.96M Jun/2025
Baxter International USD 272M 214M Jun/2025
Becton, Dickinson and Co. USD 979M 433M Jun/2025
Charles River Laboratories USD 132.33M 57.66M Jun/2025
Cooper Companies USD 175.7M 9.1M Jul/2025
Dentsply International USD 111M 48M Jun/2025
Haemonetics USD 70.84M 20.14M Jun/2025
ICU Medical USD 26.8M 2.78M Jun/2025
Insulet USD 121.1M 71.8M Jun/2025
Integra LifeSciences USD -1309000 14.65M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
J&J USD 6.94B 6.69B Jun/2025
Medtronic USD 1.52B 81M Jul/2025
Merit Medical Systems USD 47.02M 5.99M Jun/2025
Neogen USD -13254000 18.67M May/2025
Quidel USD -1800000 50.5M Jun/2025
Repligen USD 5.96M 621K Jun/2025
Solventum Corp 214M 62M Jun/2025
STAAR Surgical USD -24716000 10.02M Jun/2025
Terumo JPY 55.89B 31.71B Jun/2025
West Pharmaceutical Services USD 153.7M 46.7M Jun/2025